SUMMARY Synovial membranes surgically removed from the knees of 2 patients who had received radioactive yttrium-90 silicate have been examined. Autoradiographs showed that in both cases the activity was unevenly distributed over the synovium. One of the specimens, removed 7 weeks after administration of the isotope, was found to contain a slight degree of radioactivity, attributable in part to a long-lived radioactive contaminant.
The optimum therapeutic benefit from the use of radioactive colloids in the treatment of rheumatoid arthritis will be obtained if the isotope covers the whole of the synovial membrane and if the rate of loss of the colloid from the joint is low. In the case of the knee it is believed from scanning studies that a satisfactory distribution of the colloid occurs within a few hours (Prichard et al., 1970) . Information on the escape of activity from the knee has been provided by, for example, Dunscombe et al. (1976) , Gumpel et al. (1975) , and Ramsey (1973) . These studies have shown that over 5 days up to approximately 25 % of the injected activity can escape, though lower figures are more usual. Measurements are not normally continued beyond 5 or 6 days.
It is of interest to supplement the information already obtained with more precise measurement of the activity distribution on the synovial membrane and with some indication of the medium-term retention of radioactivity in the knee. The opportunity to study these 2 aspects of the treatment arose when the synovial membranes of 2 patients who had received 90Y silicate were surgically removed from the knee. removed 7 weeks after a therapeutic dose of 185 MBq (5 mCi) of 90Y silicate in 17 ml saline.
Materials and methods

Specimen
Autoradiographs of both specimens were produced on wrapped Kodak x-ray film, and the resultant optical densities were compared with those produced by known activities of 90Y in a layer of water of approximately the same thickness, 3 mm, as the synovial specimens. This comparison was carried out with a scanning microdensitometer.
The retention of activity in specimen B was investigated by regular counting with a 2 mm thick Nal (T1) scintillator, the associated electronics of which accepted signals corresponding to an energy deposition greater than 20 keV in the crystal. Measurements over a period of 8 weeks gave an indication of the half life of the activity in the sample and thereby assisted in its identification. Calibration of the detection system used a standard source similar to that employed for the film.
Results
Figs. 1 (a) and (b) show the autoradiographs produced by specimens removed 1 day and 7 weeks respectively after administration of the radionuclide.
The non-uniformity in blackening of the films, which drops to the background level in some regions, is too large to be due to the influence of sample thickness on the amount and energy of the radiation reaching the films and must therefore result from an uneven distribution of activity on the specimens. This non-uniformity is perhaps hardly surprising in view of the well-known heterogeneity of tissue changes in rheumatoid arthritis (Gardner, Counting measurements indicated both that activity remained on the synovium and that, due to its half life, the most abundant radionuclide present was not 90Y. A sample of blood and knee fluid obtained from this patient at operation showed no measureable activity. Using the calibration described, the count rate from the synovial membrane was computed to be that which would have been observed from an 90Y content of between 0-4 and 0 7 kBq (0 01 and 0-02 ,Ci).
Analyses performed by the manufacturers identified the contaminants as 91Y and 88y. The level of these two nuclides present in the 90Y colloid at the reference date (date of delivery), were 22 x 10-3 % activity of 9Y as 91Y, and, for 88y, 14 x 10-4% of 90Y. 90Sr and 89Sr were not identified at the limits of detection, which were respectively 2 x 10-7 and 2-6 x 10-6% activity of 90Y on the reference date. As 91Y (half life 59 days) emits f3 particles with an energy of 1 54 MeV and 88Y (half life 107 days) emits 'y rays, the main energies being 0 91 MeV (90%) and 1 85 MeV (99 %), the detection system employed would have been far more sensitive to 91Y, and it was therefore primarily this radionuclide as a contaminant and residual 90Y that were observed in the synovial specimen. The detection efficiency of the system would have been approximately the same for 91Y and 90Y, and therefore the method of estimation of the activity in the specimen is valid for either and for a mixture of the 2.
In common with most radiation synovectomy patients at this hospital the donor of specimen B had had her knee radioactivity measured for 6 days following administration of the isotope, with a decrease in the decay-corrected count rate of 14% being recorded in this period. If no further escape had occurred after the sixth day following administration of the isotope, then 2 9 kBq (0 *08 V.Ci) 90Y and 2 -5 kBq (0 * 07 [Ci) 91Y should have been present in the specimen when counting began. In fact approximately 10% of the total amount expected was actually found. Although it is possible that not all the radioactivity in the knee was removed with the Radioactivity studies on 2 synovial specimens after radiation synovectomy with yttrium-90 silicate 89 specimen, it would appear unlikely that 90 % still remained in the knee. The possibility that radioactive material continues to escape from the knee joint after the period during which measurements over the knee were made suggests itself.
Conclusions
The autoradiographic studies indicate that activity is distributed unevenly over the synovial membrane. Scanning procedures, which indicate only the gross distribution, will not give this information. It is possible that the uneven distribution of the activity may result from spatial variations in the condition of the synovium arising from the disease process within the knee.
The amount of radioactive material present on the synovial membrane, 7 weeks after administration of the radionuclide, was less than expected from calculations of the decay, allowance being made for the known impurities in the injectate. The amount of 91Y, which forms the greater part of the impurity, when administered to the patient was approximately 2% of the maximum permissible body burden for that nuclide (ICRP, 1959) . 
